yeah, right, somewhat dead, b/c IMCL outclasses onxx on various fronts and NO ONE CAN DISPUTE the FACTS / STATISTICS showing IMCL further along in
(1)development ie. availability of product
(2)efficacy ie. how well the product works
(3)rate of regression ie. how fast the tumours shrink
Again i ask, if you had cancer, which co's treatment would you choose?
a) With IMCL's 88% rate of complete regression and 100% of persons having over 50% regression, I take that over 23% complete regression or 62% of persons having over 50% regression.
b) Additionally, no/zero/nada participants with IMCL's drug developed any further growth WHEREAS with ONXX <- 4% had tumours that GOT WORSE not better!
With (a) & (b) facts, I sure as heck would not want to be going with ONXX ... and to recommend such, knowingly (ie. knowing the facts & results of the studies) WOULD BE CONSIDERED NEGLIGENT in a court of law. |
